Skip to main content
. 2020 Jun 1;13(6):11–16.

TABLE 5.

The percentage of resistant isolates who previously received or were receiving acne treatment at the time of sampling

TREATMENT TYPE NO. OF RESISTANT ISOLATES (N=22)
PRIOR TREATMENT (%) TREATMENT AT SAMPLING (%)
No treatment 10 (45.5) 11 (50)
Topical
  Antibiotic 6 (27.3) 4 (18.2)
  Azelaic acid 0 (0) 0 (0)
  Benzoyl peroxide 2 (9.1) 1 (4.5)
  Retinoid 0 (0) 5 (22.7)
Systemic
  Antibiotic 7 (31.8) 5 (22.7)
  Hormonal antiandrogens 3 (13.6) 2 (9.1)
  Retinoid 1 (4.5) 1 (4.3)